3 Drugs That Could Make-or-Break AbbVie Post author:Sam Post published:February 11, 2018 Post category:BioPharma A look at three drug approvals of vital importance to the company this year. Source: BioSpace You Might Also Like SEC Filings Reveal GlaxoSmithKline's 13% Stake in This Massachusetts Biotech November 16, 2017 AI Takes Off in Biotech, Creating Demand for High Paying Jobs of $500K Plus November 6, 2017 SurModics Announces 2017 Annual Shareholders Meeting February 8, 2017
